Literature DB >> 9746443

Presenilin expression in the ocular lens.

P H Frederikse1, J S Zigler.   

Abstract

PURPOSE: Mutations in the presenilin (PS) proteins account for the majority of early onset Alzheimer's disease (AD) cases, apparently by influencing the cleavage of the Alzheimer's disease protein (betaAPP) to form beta-amyloid (Abeta), the major component of plaques in the brains of AD patients. We reported previously that AD proteins are expressed in mammalian lenses, and that betaAPP and Abeta increased in the epithelium and outer cortex of lenses subjected to oxidative stress. This increase paralleled the increase in AP1 DNA binding activity, which has been shown to accompany proliferative oxidative stress responses. Both cataract and AD have been closely linked with oxidative stress; further, both AD and cataract occur in a majority of Down Syndrome individuals. Here we investigate the expression and post-translational processing of PS proteins in the ocular lens.
METHODS: In situ hybridization, immuohistochemical detection and immunoblot assays were used to localize mRNA and proteins expression products and determine the approximate molecular weights of the resulting proteins in ocular tissue samples.
RESULTS: We report here that PS protein and mRNA are expressed in lenses, and additionally in the cornea, and are proteolytically processed in a manner similar to that demonstrated in brain tissue. PS proteins and mRNAs were localized to the lens epithelium and outer fibers. This pattern agrees with the localization demonstrated by others for mammalian Notch-like receptor proteins. PS and Notch proteins occur together in developmentally regulated cascades of gene expression found in diverse biological systems.
CONCLUSIONS: PS expression, together with betaAPP and Abeta proteins, all associated with age-related degenerative disease, are expressed in lens and might contribute to cataractogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746443     DOI: 10.1076/ceyr.17.9.947.5135

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  16 in total

1.  Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome.

Authors:  Peter H Frederikse; Xiao-Ou Ren
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Apolipoprotein E polymorphism in patients with cataract.

Authors:  M Zetterberg; H Zetterberg; M Palmér; L Rymo; K Blennow; G Tasa; E Juronen; S Veromann; P Teesalu; J-O Karlsson; K Höglund
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

3.  miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens.

Authors:  Peter H Frederikse; Robert Donnelly; Lukasz M Partyka
Journal:  Histochem Cell Biol       Date:  2006-01-06       Impact factor: 4.304

Review 4.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

Review 5.  Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.

Authors:  T M Shah; S M Gupta; P Chatterjee; M Campbell; R N Martins
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

6.  Presenilin gene function and Notch signaling feedback regulation in the developing mouse lens.

Authors:  Mina Azimi; Tien T Le; Nadean L Brown
Journal:  Differentiation       Date:  2018-07-25       Impact factor: 3.880

7.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

8.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.

Authors:  Malin E Andersson; Madeleine Zetterberg; Gunnar Tasa; Mona Seibt-Palmér; Erkki Juronen; Pait Teesalu; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

10.  δ-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes.

Authors:  Gyungah Jun; Juliet A Moncaster; Carolina Koutras; Sudha Seshadri; Jacqueline Buros; Ann C McKee; Georges Levesque; Philip A Wolf; Peter St George-Hyslop; Lee E Goldstein; Lindsay A Farrer
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.